Monica Civallero

Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

Christopher P. Fox, Monica Civallero, Young-Hyeh Ko et al. · The Lancet Haematology · 2020 · 133 citations · Full text

Lymphoid Neoplasia, Survival Outcomes, Medicine +7

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

Ranjana H. Advani, Tetiana Skrypets, Monica Civallero et al. · Blood · 2021 · 117 citations · Full text

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas

Francine M. Foss, Steven M. Horwitz, Monica Civallero et al. · American Journal of Hematology · 2019 · 61 citations · Full text

Cell Therapy, T Cell Lymphomas, Immunology +17

Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine

Maria Cosenza, Monica Civallero, Luigi Marcheselli et al. · APOPTOSIS · 2017 · 49 citations · Full text

Anti-lymphoma Cell Activity, Medicine, Selective Hdac6 Inhibitor +8

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project

Andrei R. Shustov, María Elena Cabrera, Monica Civallero et al. · Blood Advances · 2021 · 44 citations · Full text